Implementation of an Effective Decentralised Programme for Detection, Treatment and Prevention of Tuberculosis in

John Paul Dongo1, Stephen M Graham1,2, Joseph Nsonga1

  • 1International Union against Tuberculosis and Lung Disease, Kampala P.O. Box 16094, Uganda.

Insights

Decentralizing tuberculosis (TB) services in Uganda improved detection and treatment for childhood TB. The DETECT Child TB Project successfully increased case finding and uptake of TB preventive treatment (TPT) for child contacts.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Childhood tuberculosis (TB) remains under-detected in high-burden nations like Uganda, particularly in young children.
  • Limited access to specialized services at the referral level hinders effective prevention, detection, and treatment of pediatric TB.
  • Implementation of TB preventive treatment (TPT) for child contacts is notably suboptimal.

Purpose of the Study:

  • To describe the development and implementation of the DETECT Child TB Project in Uganda.
  • To evaluate the impact of decentralizing child TB services on case finding, treatment outcomes, and TPT uptake.
  • To identify challenges and lessons learned from a community-based approach to childhood TB management.

Main Methods:

  • Decentralization of child TB services from tertiary to primary healthcare facilities.
  • Integration of community-based household contact screening and management.
  • Provision of ongoing mentorship and practical support for healthcare workers.

Main Results:

  • Improved case finding for both childhood and adult TB cases.
  • Enhanced treatment outcomes for children diagnosed with TB.
  • High uptake and completion rates for TB preventive treatment (TPT) among eligible child contacts.

Conclusions:

  • Decentralizing healthcare services and strengthening community linkages are effective strategies for improving childhood TB detection and management.
  • Ongoing support and mentorship for healthcare workers are crucial for successful implementation of TB programs.
  • The DETECT Child TB Project demonstrated a successful model for addressing childhood TB in resource-limited settings.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
281
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
246
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
427
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
711
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
548
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
37